started · updated
INSAIT launches AI drug discovery research initiative in Bulgaria
The Institute for Computer Science, Artificial Intelligence and Technology (INSAIT) at Sofia University has launched a new scientific research direction focused on using artificial intelligence to discover new drugs and treatments. The initiative aims to use AI to reveal how diseases transform human cells and to identify patterns in massive biological datasets that traditional methods might miss.
The research will integrate advancements in artificial intelligence, mathematics, and biology to predict how cells respond to various medications and to determine which substances or combinations offer the highest therapeutic potential. This approach seeks to address the challenge of the nearly infinite possible combinations of substances that laboratory experiments alone cannot fully explore.
Dr. Alexandrina Goeva, an internationally recognized Bulgarian academic, will lead this new direction. Dr. Goeva returns to Bulgaria following a career in the United States and Canada, including roles at the University of Toronto, the Broad Institute of MIT and Harvard, and Harvard University.
Entities
Alexandrina Goeva · Broad Institute of MIT and Harvard · INSAIT · Sofia University St. Kliment Ohridski · University of Toronto